# EDGAR Filing Document

**Accession Number:** 0002117213
**File Stem:** 0001213900-26-030653
**Filing Date:** 2026-3
**Character Count:** 6775
**Document Hash:** cff59c0e44e92bf67e2ad4152b0b7d75
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-030653.hdr.sgml**: 20260318

**ACCESSION NUMBER**: 0001213900-26-030653

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260318

**FILED AS OF DATE**: 20260318

**DATE AS OF CHANGE**: 20260318

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Hazan Dalit Fellous
- **CENTRAL INDEX KEY:** 0002117213

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38428
- **FILM NUMBER:** 26768712

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** GOLANI STREET 22
- **CITY:** KFAR YONA
- **PROVINCE COUNTRY:** L3
- **ZIP:** 00000
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PolyPid Ltd.
- **CENTRAL INDEX KEY:** 0001611842
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 18 HASIVIM STREET
- **CITY:** PETACH TIKVA
- **STATE:** L3
- **ZIP:** 4959376
- **BUSINESS PHONE:** 972-74-7195700

**MAIL ADDRESS:**
- **STREET 1:** 18 HASIVIM STREET
- **CITY:** PETACH TIKVA
- **STATE:** L3
- **ZIP:** 4959376

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Hazan Dalit Fellous<br><sub>(Last) (First) (Middle)</sub><br>C/O POLYPID LTD.<br>18 HASIVIM STREET<br><sub>(Street)</sub><br>PETACH TIKVA, ISRAEL 495376<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>PolyPid Ltd. [ PYPD ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-18 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Deputy CEO, EVP, RD, CRA_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Employee Stock option (right to buy) | 2017-04-04 | 2026-04-05 | Ordinary Shares | 73<sup>(1)</sup> | $92.89 | D |  |
| Employee Stock option (right to buy) | 2017-08-25 | 2026-08-24 | Ordinary Shares | 47<sup>(2)</sup> | $92.89 | D |  |
| Employee Stock option (right to buy) | 2018-02-02 | 2027-11-02 | Ordinary Shares | 199<sup>(3)</sup> | $23.07 | D |  |
| Employee Stock option (right to buy) | 2020-05-06 | 2030-02-06 | Ordinary Shares | 80<sup>(4)</sup> | $23.07 | D |  |
| Employee Stock option (right to buy) | 2021-06-11 | 2030-06-11 | Ordinary Shares | 1832<sup>(5)</sup> | $23.07 | D |  |
| Employee Stock option (right to buy) | 2023-05-09 | 2032-05-09 | Ordinary Shares | 2000<sup>(6)</sup> | $23.07 | D |  |
| Employee Stock option (right to buy) | 2022-08-09 | 2031-08-09 | Ordinary Shares | 1165<sup>(7)</sup> | $23.07 | D |  |
| Employee Stock option (right to buy) | 2024-08-07 | 2033-08-07 | Ordinary Shares | 14667<sup>(8)</sup> | $11.01 | D |  |
| Employee Stock option (right to buy) | 2024-08-06 | 2034-05-06 | Ordinary Shares | 90000<sup>(9)</sup> | $4.64 | D |  |
| Employee Stock option (right to buy) | 2025-06-09 | 2034-05-06 | Ordinary Shares | 60000<sup>(10)</sup> | $4.64 | D |  |
| Employee Stock option (right to buy) | 2025-08-12 | 2035-05-12 | Ordinary Shares | 66000<sup>(11)</sup> | $2.67 | D |  |
| Employee Stock option (right to buy) | 2025-06-09 | 2035-05-12 | Ordinary Shares | 44000<sup>(12)</sup> | $2.67 | D |  |

---

### Footnotes:

(1) The options were granted on April 5, 2016 and fully vested as of April 5, 2019.

(2) The options were granted on August 24, 2016 and fully vested as of August 24, 2019.

(3) The options were granted on November 2, 2017 and fully vested as of November 2, 2020.

(4) The options were granted on February 6, 2020 and fully vested as of February 6, 2023.

(5) The options were granted on June 11, 2020 and fully vested as of June 11, 2024.

(6) The options were granted on May 9, 2022 and vest on a quarterly basis beginning May 9, 2023 until May 9, 2026.

(7) The options were granted on August 9, 2021 and fully vested as of August 9, 2025.

(8) The options were granted on August 7, 2023 and vest on a quarterly basis beginning August 7, 2024 until August 7, 2027.

(9) The options were granted on May 6, 2024 and vest on a quarterly basis until May 6, 2028.

(10) The options were granted on May 6, 2024 and vest on a quarterly basis until May 6, 2026.

(11) The options were granted on May 12, 2025 and vest on a quarterly basis until May 12, 2029.

(12) The options were granted on May 12, 2025 and vest on a quarterly basis until May 12, 2027.

**Signature:** /s/ Dalit Fellous Hazan  
**Date:** 2026-03-18

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**